Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Correlation of Single Nucleotide Polymorphism (SNP) Profile of Domain III of EGFR to Skin Toxicity and Disease Response to Treatment With Erbitux Requirements

NCT01726309 is registered in ClinicalTrials.gov with Cancer Trials Ireland as lead sponsor.

NCT NCT01726309
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01726309 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Correlation of Single Nucleotide Polymorphism (SNP) Profile of Domain III of EGFR to Skin Toxicity and Disease Response to Treatment With Erbitux Requirements
Lead sponsor
Cancer Trials Ireland
Phase
Observational
Overall status
Terminated
Start date
May 31, 2011
Completion date
May 11, 2021
Enrollment
161 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, non-small cell lung cancer